Policy, Progress & Prevention: A Shared Vision for Healthier Futures for Women and Girls
April 27, 2026
AWHP CEO Millicent Gorham reflects on our third annual Leadership Meeting.
Thanking Members of Congress for Leadership on the Women and Lung Cancer Research and Preventive Services Act (H.R. 2319)
April 22, 2026 - GO2 for Lung Cancer
FY27 Appropriations Request Calling on CMS to Adopt Changes to Improve Post-Fracture Care
April 20, 2026 - Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education and Related Agencies
Testimony in Support of NH SB455
April 14, 2026 - New Hampshire House Commerce and Consumer Affairs Committee
AWHP provided testimony in support of SB455, which would improve access to FDA-approved obesity management medications for Medicaid beneficiaries.
Urging Reconsideration of the Proposed Removal of Rhode Island Medicaid Coverage for Obesity Management Medications When Prescribed Solely for Weight Loss
April 8, 2026 - Rhode Island Governor Dan McKee
AWHP expressed its disappointment with the recently proposed removal of Rhode Island Medicaid coverage for obesity management medications when prescribed solely for weight loss.
Urging Reconsideration of the Proposed Removal of Rhode Island Medicaid Coverage for Obesity Management Medications When Prescribed Solely for Weight Loss
April 8, 2026 - Rhode Island Senate Finance Committee
AWHP expressed its disappointment with the recently proposed removal of Rhode Island Medicaid coverage for obesity management medications when prescribed solely for weight loss.
Support for Louisiana SB 433
April 7, 2026 - Louisiana Senate Committee on Health and Welfare
AWHP expressed its strong support for Louisiana Senate Bill 433 (SB 433), which would expand access to comprehensive obesity treatment by requiring the state’s Medicaid managed care organizations to cover obesity management medications.
Letter to the Editor: The case for expanding Medicaid coverage of obesity care
April 7, 2026 - LINK nky
AWHP CEO Millicent Gorham wrote a letter to the editor discussing her concern by the Kentucky Senate’s decision to continue its outdated ban on Medicaid coverage of GLP-1 medications for the treatment of obesity.
The Women’s Health Market Is Poised to Reach $600B by 2030. That’s if ‘We Do Nothing’
April 5, 2026 - MedCityNews
AWHP CEO Millicent Gorham commented on the release of a new report on the women’s health market by emphasizing the importance of preventive care.